Regarding the repurposing of drugs for SCA3 that have positive preclinical data, caffeine likely has a benign course with chronic administration, but can eventually lose effect due to desensitization as previously reported [267]
Safety Monitoring Monitor participants for potential adverse events throughout the study period
Our findings are in agreement with other recent observations using similar ligature models, which show a considerable increase of the distance between the cemento-enamel junction and the alveolar crest, regarded as a sign of alveolar bone loss (48, 52)
Limitations and Future Directions Research Limitations At present, clinical studies of BPC 157 mostly focus on small-sample trials, lacking evidence from large-scale, multi-center, randomized controlled trials (RCTS)
# Can You Mix Peptides in the Same Syringe